Jeffry G Weers (Jeffry Weers)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 5

Top Topics

Pulmonary Arterial Hypertension

Pseudomonas Aeruginosa

Top Venues

Molecular pharmaceutics

Pulmonary therapy

Pulmonary circulation

This page only lists publications with an associated author ORCID identifier.

Publications

Yoen-Ju Son, Danforth P Miller, Jeffry G Weers
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics 13 (9) (2021)
Adriano R Tonelli, Royanne Holy, Shirley Lyons, Edwin Parsley, Mari Maurer, Jeffry G Weers
Impact of human behavior on inspiratory flow profiles in patients with pulmonary arterial hypertension using AOS™ dry powder inhaler device. Pulmonary circulation 11 (1) (2021)
Danforth P Miller, Thomas E Tarara, Jeffry G Weers
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations. Pharmaceutics 13 (11) (2021)
Jeffry G Weers
Comparison of Phospholipid-Based Particles for Sustained Release of Ciprofloxacin Following Pulmonary Administration to Bronchiectasis Patients. Pulmonary therapy 5 (2) (2019)
Danforth P Miller, Trixie Tan, John Nakamura, Richard J Malcolmson, Thomas E Tarara, Jeffry G Weers
Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle Formulation. Molecular pharmaceutics 14 (6) (2017)